Home / People / Marek Blaszyk

Marek Blaszyk

Trainee
Patent Attorney

Portrait ofMarek Blaszyk

Marek Blaszyk

Trainee
Patent Attorney

Contact
CMS Cameron McKenna Nabarro Olswang LLP
Cannon Place
78 Cannon Street
London
EC4N 6AF
United Kingdom
Languages Polish, English

Marek is a trainee patent attorney in the IP department.

Prior to joining CMS Marek studied Biomedical Sciences at the University of Dundee, focusing on molecular biology and targeted protein degradation techniques. Marek also spent a year on an industrial placement at AstraZeneca in Gothenburg, where he explored the use of cell-free protein expression for gene editing applications. 

more less

Education

  • 2022 – M. Sci. Biomedical Sciences, University of Dundee, Dundee
more less

Expertise

Feed

07/11/2023
Description amendments at the EPO – the Appellant agrees with the need...
Description amendments bringing the content of the description in line with the allowed claims remain a controversial topic in the European practice. As reported previously, the Board of Appeal in T0056/21...
Law-Now Intellectual Property
28/07/2023
Description amendments at the EPO – uncertainty for not (too) much longer?...
Amending the description to conform with the claims remains a challenging element of European patent practice, particularly in view of the divergent case law in the subject, and varied approaches taken...
Law-Now Intellectual Property
06/04/2023
G1/22 and G2/22 – Preliminary opinion of the Enlarged Board of Appeal
On 21 March 2023 the Enlarged Board of Appeal (EBA) issued a preliminary opinion in consolidated cases G1/22 and G2/22 (“pri­or­ity”), which provides some initial insight into the possible outcome of...
Law-Now Intellectual Property
22/03/2023
European Patent Office (EPO) level of disclosure required for antibodies...
As a complement to the 10th edition of the EPO "Case Law of the Boards of Appeal" (CLB), the EPO has published an Annual Review containing summaries of decisions from 2022. The review provides a thematic...
Law-Now Life Sciences & Healthcare
16/12/2022
Armchair inventions part 2:  Preliminary opinion on plausibility at the...
The issue of plausibility was previously referred to the Enlarged Board of Appeal (EBA), the highest judicial authority at the European Patent Office (EPO). Our article on the referral can be found here...
Law-Now Consumer Products